Arundhati Dongre
Cathepsin K in lymphangioleiomyomatosis: LAM cell-fibroblast Interactions enhance protease activity by extracellular acidification
Dongre, Arundhati; Clements, Debbie; Fisher, Andrew J.; Johnson, Simon R.
Authors
Dr DEBBIE CLEMENTS DEBBIE.CLEMENTS@NOTTINGHAM.AC.UK
RESEARCH ASSOCIATE
Andrew J. Fisher
Professor SIMON JOHNSON simon.johnson@nottingham.ac.uk
PROFESSOR OF RESPIRATORY MEDICINE
Abstract
Lymphangioleiomyomatosis (LAM) is a rare disease in which clonal ‘LAM’ cells infiltrate the lungs and lymphatics. In association with recruited fibroblasts, LAM cells form nodules adjacent to lung cysts. It is assumed LAM nodule derived proteases lead to cyst formation although, this is uncertain. We profiled protease gene expression in whole lung tissue and observed cathepsin K was 40 fold over-expressed in LAM compared with control lungs (p≤0.0001). Immunohistochemistry confirmed cathepsin K protein in LAM nodules but not control lungs. Cathepsin K gene expression, protein and protease activity was detected in LAM associated fibroblasts but not the LAM cell line 621-101. In lung nodules, cathepsin K immune reactivity was predominantly co-localised with LAM associated fibroblasts. In vitro, extra-cellular cathepsin K activity was minimal at pH 7.5 but significantly enhanced in fibroblast cultures at pH 7 and 6. 621-101 cells reduced extracellular pH by 0.5 units over 24 hours. Acidification was dependent upon 621-101 cell mTOR activity and net hydrogen ion transporters, particularly sodium/bicarbonate co-transporters and carbonic anhydrases which were also expressed in LAM lung tissue. In LAM cell/fibroblast co-cultures, acidification paralleled cathepsin K activity and both were inhibited by sodium bicarbonate co-transporter (p≤0.0001) and carbonic anhydrase inhibitors (p=0.0021). Our findings suggest cathepsin K activity is dependent on LAM cell/fibroblast interactions and inhibitors of extracellular acidification may be potential therapies for LAM.
Citation
Dongre, A., Clements, D., Fisher, A. J., & Johnson, S. R. (2017). Cathepsin K in lymphangioleiomyomatosis: LAM cell-fibroblast Interactions enhance protease activity by extracellular acidification. American Journal of Pathology, 187(8), 1750-1762. https://doi.org/10.1016/j.ajpath.2017.04.014
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 26, 2017 |
Online Publication Date | Jun 15, 2017 |
Publication Date | 2017-08 |
Deposit Date | May 17, 2017 |
Publicly Available Date | Jun 15, 2017 |
Journal | The American Journal of Pathology |
Print ISSN | 0002-9440 |
Electronic ISSN | 1525-2191 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 187 |
Issue | 8 |
Pages | 1750-1762 |
DOI | https://doi.org/10.1016/j.ajpath.2017.04.014 |
Public URL | https://nottingham-repository.worktribe.com/output/967115 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S0002944017303711 |
Contract Date | May 17, 2017 |
Files
Cathepsin K in LAM figures R1 corrected_3.pdf
(2.6 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
Cathepsin K in LAM body text.pdf
(279 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
You might also like
Mast Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis
(2021)
Journal Article
MMP-1 activation contributes to airway smooth muscle growth and asthma severity
(2016)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search